Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
___________________________________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
 
Date of report (Date of earliest event reported):   November 23, 2010

CHINA SKY ONE MEDICAL, INC.
(Exact Name of Registrant as Specified in Charter)

Nevada
000-26059
87-0430322
(State or Other Jurisdiction
(Commission
(IRS Employer
of Incorporation)
File Number)
Identification No.)

No. 2158, North Xiang An Road, Song Bei District,
Harbin, People’s Republic of China 150028
(Address of Principal Executive Offices)

Registrant's telephone number, including area code:    86-451-87032617 (China)
 
    
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Item 3.02.
Unregistered Sales of Equity Securities.
 
As of November 23, 2010, China Sky One Medical, Inc. (the “Company”) issued an aggregate of 149,688 shares of it’s common stock (the “Shares”) to 28 recipients (the “Recipients”) under the Company’s 2006 Stock Incentive Plan.  The Shares were issued in consideration for services rendered by the Recipients to the Company, and were valued at a price of $7.34 per share, the last reported closing price of shares of the Company’s common stock on the Nasdaq Global Select Market as of the date of issuance.

The Company believes that the issuance of the Shares in these transactions is exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(2), and/or Regulation D promulgated thereunder, as a transaction by an issuer not involving a public offering.

Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
Reference is made to the disclosure set forth under Item 3.02 above, which disclosure is incorporated herein by reference.  Included among the Recipients are certain executive officers and directors of the Company, as follows:

Name
Title
  
Number of Shares
  
Liu Yan-qing
President, Chief Executive Officer and Chairman of the Board of Directors (principal executive officer)
     37,374  
Han Xiao-yan
Vice Chairman and Director
     28,654  
Pan Hong-yu
Chief Financial Officer and Treasurer (principal financial and accounting officer)
     1,500  
Hao Yu-bo
Vice President, Secretary and Director
     12,458  
William Wei Lee
Independent Director
     2,076  
Zhao Jie
Independent Director
     1,662  
Song Chun-fang
Independent Director
     1,662  
Qian Xu-feng
Independent Director
     1,662  

The issuances were recommended by unanimous written consent of the Company’s Compensation Committee, and authorized by unanimous written consent of the Company’s Board of Directors, as of November 23, 2010.

Item 9.01.
Financial Statements and Exhibits
 
(d)     
Exhibits.

The exhibits listed in the following Exhibit Index are filed as part of this Form 8-K.

Exhibit No.
  
Description
     
4.1
  
2006 Stock Incentive Plan – Incorporated by reference to the Company’s Definitive Information Statement on Schedule 14C, filed on July 6, 2006
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
      CHINA SKY ONE MEDICAL, INC.  
        (Registrant)  
           
           
Date:  
November 30, 2010  
  
By:
/s/ Liu Yan-qing  
        Liu Yan-qing  
       
Chairman, Chief Executive Officer and President